BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8164041)

  • 1. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
    Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
    J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age.
    Behm FG; Raimondi SC; Frestedt JL; Liu Q; Crist WM; Downing JR; Rivera GK; Kersey JH; Pui CH
    Blood; 1996 Apr; 87(7):2870-7. PubMed ID: 8639906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
    Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
    Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
    Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance and frequency of the 11q23/MLL genetic molecular alteration in Chilean infants with acute leukemia].
    Cabrera ME; Campbell M; Quintana J; Undurraga MS; Ford AA; Greaves MF
    Rev Med Chil; 2001 Jun; 129(6):634-42. PubMed ID: 11510203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
    Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features.
    Raimondi SC; Frestedt JL; Pui CH; Downing JR; Head DR; Kersey JH; Behm FG
    Blood; 1995 Sep; 86(5):1881-6. PubMed ID: 7655016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
    Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
    J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia.
    Hilden JM; Smith FO; Frestedt JL; McGlennen R; Howells WB; Sorensen PH; Arthur DC; Woods WG; Buckley J; Bernstein ID; Kersey JH
    Blood; 1997 May; 89(10):3801-5. PubMed ID: 9160687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
    Ramakers-van Woerden NL; Beverloo HB; Veerman AJ; Camitta BM; Loonen AH; van Wering ER; Slater RM; Harbott J; den Boer ML; Ludwig WD; Haas OA; Janka-Schaub GE; Pieters R
    Leukemia; 2004 Mar; 18(3):521-9. PubMed ID: 14712291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
    Hilden JM; Dinndorf PA; Meerbaum SO; Sather H; Villaluna D; Heerema NA; McGlennen R; Smith FO; Woods WG; Salzer WL; Johnstone HS; Dreyer Z; Reaman GH;
    Blood; 2006 Jul; 108(2):441-51. PubMed ID: 16556894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.
    Borkhardt A; Wuchter C; Viehmann S; Pils S; Teigler-Schlegel A; Stanulla M; Zimmermann M; Ludwig WD; Janka-Schaub G; Schrappe M; Harbott J
    Leukemia; 2002 Sep; 16(9):1685-90. PubMed ID: 12200682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings.
    Watanabe N; Kobayashi H; Ichiji O; Yoshida MA; Kikuta A; Komada Y; Sekine I; Ishida Y; Horiukoshi Y; Tsunematsu Y; Yano M; Nakadate H; Kaneko Y
    Leukemia; 2003 May; 17(5):876-82. PubMed ID: 12750700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of infant acute leukemia.
    Hilden JM; Frestedt JL; Kersey JH
    Leuk Lymphoma; 1997 Apr; 25(3-4):191-9. PubMed ID: 9168430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
    Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
    J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
    Stock W; Thirman MJ; Dodge RK; Rowley JD; Diaz MO; Wurster-Hill D; Sobol RE; Davey FR; Larson RA; Westbrook CA
    Leukemia; 1994 Nov; 8(11):1918-22. PubMed ID: 7967737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23.
    Gill Super HJ; Rothberg PG; Kobayashi H; Freeman AI; Diaz MO; Rowley JD
    Blood; 1994 Feb; 83(3):641-4. PubMed ID: 8298125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96).
    Isoyama K; Eguchi M; Hibi S; Kinukawa N; Ohkawa H; Kawasaki H; Kosaka Y; Oda T; Oda M; Okamura T; Nishimura S; Hayashi Y; Mori T; Imaizumi M; Mizutani S; Tsukimoto I; Kamada N; Ishii E
    Br J Haematol; 2002 Sep; 118(4):999-1010. PubMed ID: 12199778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.